(Q54643443)

English

Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers. (English)

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

cholangiocarcinoma

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Xiao-Bo Man

1

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Liang Tang

2

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Bao-Hua Zhang

3

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Shen-Jing Li

4

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Xiu-Hua Qiu

5

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Meng-Chao Wu

6

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Hong-Yang Wang

7

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

publication date

1 October 2005

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Liver International

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

25

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

5

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

962-966

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Cholangiocarcinoma: Current concepts and insights

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Glypicans: proteoglycans with a surprise

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Expression of OCI-5/glypican 3 during intestinal morphogenesis: regulation by cell shape in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Glypican-3 expression is silenced in human breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Glypican-3 is overexpressed in human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Anatomic and molecular pathology of intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Classification of cancers by expression profiling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01100.X

21 January 2018

Identifiers

10.1111/J.1478-3231.2005.01100.X

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/16162153

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54643443&oldid=1501720815"